Grant
Targeting MET for the Treatment of Lung Cancer Patients with MET Exon 14 Mutation may be Associated with Improved Survival and Decreased Morbidity
Targeting MET for the Treatment of Lung Cancer Patients with MET Exon 14 Mutation may be Associated with Improved Survival and Decreased Morbidity